Warning! GuruFocus detected
2 Severe warning signs
with 6FN.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Klaria Pharma Holding AB
ISIN : SE0007280326
Compare
Compare
Traded in other countries / regions
KLAR.Sweden6FN.Germany IPO Date
2021-06-07Description
Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.06 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 39.4 | |||||
| 3-Year EPS without NRI Growth Rate | 37 | |||||
| 3-Year FCF Growth Rate | 40.2 | |||||
| 3-Year Book Growth Rate | -73.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.61 | |||||
| 9-Day RSI | 52.58 | |||||
| 14-Day RSI | 52.19 | |||||
| 3-1 Month Momentum % | 393.8 | |||||
| 6-1 Month Momentum % | 82.16 | |||||
| 12-1 Month Momentum % | 778.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.05 | |||||
| Quick Ratio | 0.05 | |||||
| Cash Ratio | 0.01 | |||||
| Days Sales Outstanding | 516.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.9 | |||||
| Shareholder Yield % | 0.01 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1740.9 | |||||
| Net Margin % | -4479.36 | |||||
| FCF Margin % | -932.26 | |||||
| ROE % | -222.35 | |||||
| ROA % | -72.49 | |||||
| ROIC % | -25.05 | |||||
| 3-Year ROIIC % | -255.35 | |||||
| ROC (Joel Greenblatt) % | -53.7 | |||||
| ROCE % | -57.74 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 2.09 | |||||
| PS Ratio | 182.14 | |||||
| PB Ratio | 55.43 | |||||
| EV-to-EBIT | -11.13 | |||||
| EV-to-Forward-EBIT | 1.01 | |||||
| EV-to-EBITDA | -13.52 | |||||
| EV-to-Forward-EBITDA | 1.01 | |||||
| EV-to-Revenue | 193.55 | |||||
| EV-to-Forward-Revenue | 0.45 | |||||
| EV-to-FCF | -20.6 | |||||
| Price-to-GF-Value | 11.15 | |||||
| Earnings Yield (Greenblatt) % | -8.99 | |||||
| FCF Yield % | -5.21 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Klaria Pharma Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.093 | ||
| EPS (TTM) (€) | -0.035 | ||
| Beta | 4.38 | ||
| 3-Year Sharpe Ratio | 0.47 | ||
| 3-Year Sortino Ratio | 1.66 | ||
| Volatility % | 442.03 | ||
| 14-Day RSI | 52.19 | ||
| 14-Day ATR (€) | 0.008202 | ||
| 20-Day SMA (€) | 0.10442 | ||
| 12-1 Month Momentum % | 778.68 | ||
| 52-Week Range (€) | 0.0046 - 0.147 | ||
| Shares Outstanding (Mil) | 144.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Klaria Pharma Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Klaria Pharma Holding AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Klaria Pharma Holding AB Frequently Asked Questions
What is Klaria Pharma Holding AB(STU:6FN)'s stock price today?
The current price of STU:6FN is €0.11. The 52 week high of STU:6FN is €0.15 and 52 week low is €0.00.
When is next earnings date of Klaria Pharma Holding AB(STU:6FN)?
The next earnings date of Klaria Pharma Holding AB(STU:6FN) is 2025-05-21.
Does Klaria Pharma Holding AB(STU:6FN) pay dividends? If so, how much?
Klaria Pharma Holding AB(STU:6FN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers